The U.K.’s National Institute for Health and Care Excellence (NICE) has recommended the anticoagulant rivaroxaban as a possible treatment for adults with pulmonary embolism and to prevent recurrent deep vein thrombosis or pulmonary embolism.

A new $11 million grant to Kaiser Permanente Northern California and UC San Francisco will support a multifaceted research program aimed at lowering stroke risk among black populations and younger stroke victims by targeting high blood pressure, also known as hypertension.

Fifteen minutes sooner, four in 1,000 more lives saved. That appears to be the benefit ratio for timely reperfusion of patients who present with acute ischemic stroke, according to results published June 19 in JAMA.

Minneapolis-based Medtronic has launched a new peripheral balloon catheter after it was given thumbs up in the U.S. and Europe.

The FDA has given 510(k) clearance to Aptus Endosystems for its 28mm Tip Reach Heli-FX Guide, a longer reach guide catheter used in the treatment of wide neck abdominal aortic aneurysms.

The FDA approved Medtronic’s Endurant II Aorto-Uni-Iliac (AUI) Stent Graft System and gave 510(k) clearance for the Sentrant Introducer Sheath.

The FDA has issued a Class I recall of Zilver PTX Drug-Eluting Peripheral Stent.

A CREST substudy found that performing balloon angioplasty after carotid artery stenting reduced the risk of restenosis by 64 percent but increased the risk of stroke. The stroke finding was not statistically significant, though. Results were presented May 9 at the Society of Cardiovascular Angiography and Interventions (SCAI) scientific sessions in Orlando, Fla.